The Board of Pharmacy announced that the Collaborative Drug Therapy Management Committee adopted several protocols for testing and initiation of therapy for:
– Suspected Influenza in Adult Patients
– Suspected Influenza in Patients under 18 years of age
– Suspected Acute Group A Streptococcal Pharyngitis in Adult Patients
– Suspected Acute Group A Streptococcal Pharyngitis in Patients under 18 years of age
– Suspected Acute Uncomplicated Lower Urinary Tract Infection in Women

Also in Kansas, the Board of Pharmacy approved a new emergency opioid antagonist (EOA) protocol adding an opioid antagonist drug ready-to-use nasal spray device to the drugs that may be dispensed.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

The Board of Pharmacy published a guidance document for pharmacy technicians and pharmacy interns administering immunizations. 

For more information, contact NACDS’ Mary Staples at 817-442-1155.

The Board of Pharmacy published a guidance document for pharmacy technicians administering immunizations.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

Prior to the legislature adjourning on April 28, SB 131, legislation that was amended to include extending the authority for pharmacy technicians to administer vaccines was sent to Gov. Laura Kelly (R). She signed it into law on May 1. 

For more information, contact NACDS’ Mary Staples at 817-442-1155.

HB 2263, the pharmacy technician vaccine administration bill, continues to advance. It was heard in the Senate Public Health and Welfare Committee on March 15^th.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

HB 2263, the pharmacy technician vaccine administration bill, was amended in Committee and passed the full House by a vote of 119-3. This bill was referred to the Senate Public Health and Welfare Committee and will be heard on March 15.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

HB 2263, legislation that would add pharmacy technicians over 18 years of age to the list of those that can administer vaccinations under Kansas law was amended and reported favorable from the House Health and Human Services Committee on February 6. Next, the bill goes to the full House. NACDS pharmacist and technician constituents are urged to contact their state representative and ask them to vote for HB 2263.  

For more information, contact NACDS’ Mary Staples at 817-442-1155.

Prior to adjournment last month, Gov. Laura Kelly (D) signed into law SB (Senate Bill) 200, a bill expanding the pharmacist’s scope of practice to include initiation of therapy for flu, strep or urinary tract infection pursuant to a Statewide Protocol adopted by the existing Collaborative Drug Therapy Management Advisory Committee. Also signed into law was SB 28 that sets up a regulatory framework, adjusts the MAC (Maximum Allowable Cost) appeal law, and requires Pharmacy Benefit Managers to be licensed by the Insurance Department. 

For more information, contact NACDS’ Mary Staples at 817-442-1155.

Two Senate bills advancing of interest to pharmacies were amended and are now pending action by the full House. SB 200 allows pharmacists to test and initiate therapy for strep, flu, and urinary tract infections under protocols developed and approved by the Collaborative Drug Therapy Management Advisory Committee. SB 28 requires PBMs (Pharmacy Benefits Managers) to be licensed and regulated by the Insurance Department. It also addresses MAC (Maximum Allowable Cost) pricing and delineates what items a PBM (Pharmacy Benefit Manager) can request during a MAC appeal. If these bills pass the House, they will be returned to the Senate for ultimate action to concur with the House changes. 

For more information, contact NACDS’ Mary Staples at 817-442-1155.